Brisbane Times Proteomics locks in US patent for throat cancer test
Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of esophageal cancer in at-risk patients.
Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of esophageal cancer in at-risk patients.